Key FInancial »

Xilio Therapeutics shares owned by Key FInancial

Quarter-by-quarter ownership of Xilio Therapeutics shares owned by Key FInancial from 13F filings

Historical chart of Key FInancial investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Key FInancial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Key FInancial

Quarter filed Position value Share count Share price at filing
2026-03-31 $496 59 8.41

More positions owned by Key FInancial

Apple (AAPL)
Wisdomtree Tr True Developed I (DOL)
Wisdomtree Tr Global Ex Us Qua (DNL)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Series Trust State Street Spd (SLYV)
Wisdomtree Tr Us Smallcap Fund (EES)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Grwth Etf (EFG)
First Tr Exchange Traded Intl Dev Strngth (FICS)
Spdr Series Trust State Street Spd (SPYV)
Wisdomtree Tr Us Largecap Divd (DLN)
Invesco Exch Trd Slf Idx Bulshs 2027 Muni (BSMR)
Spdr Series Trust State Street Spd (SPYG)
Exxon Mobil Corporation (XOM)

View all positions for Key FInancial

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Frazier Life Sciences Management
Vanguard Capital Management
Merck & Co
Morgan Stanley
AJU IB Investment
Geode Capital Management
Vanguard Fiduciary Trust
GSA Capital Partners
Ghisallo Capital Management
UBS Group
Vanguard Global Advisers
Royal Bank of Canada
Key FInancial

View all funds holding Xilio Therapeutics